SITC Sessions at Society of Interventional Oncology's (SIO) 2026 NEXT Summit

Starts:  May 28, 2026 00:00 (CT)
Ends:  May 29, 2026 00:00 (CT)

The Society for Immunotherapy of Cancer (SITC) is proud to collaborate with the Society of Interventional Oncology (SIO) for joint sessions, "When Combination Therapies Fail in HCC: Scientific Insights and Future Directions" and "Intratumoral Therapies in IO: Mechanisms, Delivery and Clinical Integration" at the upcoming SIO 2026 NEXT Summit. These sessions will feature SITC and SIO experts, and the 2026 program expands its scope beyond HCC and liver cancers to include additional disease states, highlighting novel therapeutic applications and next-generation combination approaches that reflect the rapidly evolving patient care landscape and support forward-looking treatment strategies.

SITC members, please use code SITC26NEXT for a discounted registration.

The SIO 2026 NEXT Summit will be held May 28-29, 2026 at the Gleacher Center in Chicago, IL. 

SITC Session #2:

When Combination Therapies Fail in HCC: Scientific Insights and Future Directions

May 28, 2026 | Moderators: (IR) Terence P. Gade, MD, PhD; (MDP) Tullia Bruno, PhD

Molecular Drivers of Resistance in HCC 
James Harding, MD MSKCC

Tumor Microenvironment and Immune Evasion
Lucianne Kagohara, PhD

Still Unanswered Trial Questions 
Daneng Li, MD

Strategies to Overcome Resistance: Emerging Therapies
James Zhe Hui, MD, PhD 

SITC Session #5:

Intratumoral Therapies in IO: Mechanisms, Delivery, and Clinical Integration

May 28, 2026 | Moderators: (IR) Rony Avritscher, MD, FSIR; (MDP): Tullia Bruno, PhD

Intratumoral Immunotherapy: Mechanisms and Early Data
Kevin Soares, MD, MSc

Novel Agents for Direct Tumor Injection
Michael Wong, MD, PhD, FRCPC

Minimal Residual Disease and ctDNA
Jun Gong, MD

Logistics & Tips for Effective Delivery
Rony Avritscher, MD, FSIR

More information

Location

Gleacher Conference Center
450 Cityfront Plaza Dr
Chicago, IL 60611

Related Content